Thyroid-stimulating hormone receptor autoantibodies (TRAbs) play a crucial role as pathogenic antibodies in both the diagnosis and management of Graves' disease (GD). GD, an autoimmune disease resulting from a combination of genetic and environmental factors, is the most common cause of hyperthyroidism. With advancements in technology for TRAb detection and the availability of automated commercial kits, TRAb has become an essential clinical laboratory marker for the diagnosis of GD, as well as extra-thyroidal manifestations like Graves' ophthalmopathy (GO). This article provides a comprehensive review of TRAb, encompassing its clinical assays along with its significance in the clinical setting.
Keywords: Bioassay; Graves' disease; Immunoassay; Stimulating autoantibodies; Thyroid-stimulating hormone receptor autoantibodies; Thyroid-stimulating immunoglobulin.
Copyright © 2024 Elsevier B.V. All rights reserved.